Human Papillomavirus (HPV) Nucleic Acid Detection Kit (Fluorescent PCR Method)
BIOTRON HPV Panel (BHP)
This kit is intended for the in vitro qualitative detection of 18 HPV genotypes in human cervical exfoliated epithelial cells, with specific genotyping for HPV 16 and HPV 18, including:
Comply with WHO, NMPA, NCCN, ASCCP, ACOG and other authoritative guidelines and the National Health Commission'srequirements for the detection of 14 high-risk HPV genotypes.
Regulatory Status：
DESCRIPTION
Main clinical applications
Help to identify carcinogenic risk and guide clinical management.
Efficient and Economical Large-Scale Cervical Cancer Screening
For cervical cancer screening and prevention in women aged 25–64 years.
Triage of ASCUS
To guide referral for colposcopy.
Follow-up and postoperative monitoring
To effectively predict the risk of residual or recurrent cervical lesions or cancer after treatment.
SPECIFICATION
Compliant with domestic and international guideline recommendations
Complies with WHO, NMPA, NCCN, ASCCP, ACOG and other authoritative guidelines for the detection of 14 high-risk HPV genotypes.
Balances primary screening and triage, with high efficiency and economy
Detects 18 high- and intermediate-risk HPV genotypes with specific genotyping for HPV 16 and HPV 18, and guides clinical risk stratification.
Platform-compatible, results available in 2 hours
Compatible with standard four-channel real-time PCR systems, improving testing accessibility.
Single-tube detection with high throughput
Processes up to 94 samples per batch in a single tube, satisfying large-scale population screening requirements.
Closed-tube operation with full-process quality control
High biosafety, accurate results, and reduced risk of false negatives.
Request
